One major obstacle to precision medicine for all? The cost of sequencing each person’s genome. New sequencing startups could change that.
With a new genome sequence, more diverse data sets, and population-specific projects, scientists are making progress in representing humanity’s real DNA diversity.
At a genomics conference last week, National Institutes of Health official Kathy Hudson provided an update on the government’s gigantic Precision Medicine Initiative (PMI). NIH aims to make real progress before the next president takes...